Do n-3 polyunsaturated fatty acids increase or decrease lipid peroxidation in humans?

Nirvair S. Kelley, Yasukazu Yoshida, Kent L Erickson

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: Despite many known health benefits of n-3 polyunsaturated fatty acids (PUFA), there is a concern that their high degree of unsaturation may actually increase oxidative stress, lipid peroxidation (LPO), and chronic inflammatory diseases.

Methods: In this review, we have analyzed results from published human studies regarding the effects of n-3 PUFA supplementation on markers of lipid peroxidation.

Results: Of the 22 published human studies, nine found no change, eight a decrease, and five an increase in markers of LPO. These inconsistencies may be due to methods, subject characteristics, dose, duration, fatty acid and antioxidant composition of supplements, and basal diets. Methods used for analysis seem to be the most significant factor. Six of eight studies with a decrease in LPO determined F2-isoprostanes produced in vivo, and two determined plasma antioxidant capacity or hydroperoxides. n-3 PUFA can serve as scavengers for free radicals and also modulate expression of genes that determine the balance between oxidative and antioxidative status. Recent studies that monitored oxidation products of cholesterol and fatty acids support the hypothesis that n-3 PUFA decrease LPO. Most of the studies showing no change or increase in LPO determined markers that involved ex vivo sample preparation or oxidation (malondialdehyde, low-density lipoprotein oxidation, lipid hydroperoxides).

Conclusion: A majority of studies do not indicate that n-3 PUFA increased LPO. Future studies need to investigate the effects of dose, duration, and composition of n-3 PUFA with standardized diets and methods on concentrations and types of LPO products produced.

Original languageEnglish (US)
Pages (from-to)403-415
Number of pages13
JournalMetabolic Syndrome and Related Disorders
Volume12
Issue number8
DOIs
StatePublished - Oct 1 2014

Fingerprint

Omega-3 Fatty Acids
Lipid Peroxidation
Fatty Acids
Antioxidants
F2-Isoprostanes
Diet
Free Radical Scavengers
Lipid Peroxides
Insurance Benefits
Malondialdehyde
LDL Lipoproteins
Hydrogen Peroxide
Oxidative Stress
Chronic Disease
Cholesterol
Gene Expression

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Do n-3 polyunsaturated fatty acids increase or decrease lipid peroxidation in humans? / Kelley, Nirvair S.; Yoshida, Yasukazu; Erickson, Kent L.

In: Metabolic Syndrome and Related Disorders, Vol. 12, No. 8, 01.10.2014, p. 403-415.

Research output: Contribution to journalArticle

@article{470098d3376149e78152e3f9b13da77d,
title = "Do n-3 polyunsaturated fatty acids increase or decrease lipid peroxidation in humans?",
abstract = "Background: Despite many known health benefits of n-3 polyunsaturated fatty acids (PUFA), there is a concern that their high degree of unsaturation may actually increase oxidative stress, lipid peroxidation (LPO), and chronic inflammatory diseases.Methods: In this review, we have analyzed results from published human studies regarding the effects of n-3 PUFA supplementation on markers of lipid peroxidation.Results: Of the 22 published human studies, nine found no change, eight a decrease, and five an increase in markers of LPO. These inconsistencies may be due to methods, subject characteristics, dose, duration, fatty acid and antioxidant composition of supplements, and basal diets. Methods used for analysis seem to be the most significant factor. Six of eight studies with a decrease in LPO determined F2-isoprostanes produced in vivo, and two determined plasma antioxidant capacity or hydroperoxides. n-3 PUFA can serve as scavengers for free radicals and also modulate expression of genes that determine the balance between oxidative and antioxidative status. Recent studies that monitored oxidation products of cholesterol and fatty acids support the hypothesis that n-3 PUFA decrease LPO. Most of the studies showing no change or increase in LPO determined markers that involved ex vivo sample preparation or oxidation (malondialdehyde, low-density lipoprotein oxidation, lipid hydroperoxides).Conclusion: A majority of studies do not indicate that n-3 PUFA increased LPO. Future studies need to investigate the effects of dose, duration, and composition of n-3 PUFA with standardized diets and methods on concentrations and types of LPO products produced.",
author = "Kelley, {Nirvair S.} and Yasukazu Yoshida and Erickson, {Kent L}",
year = "2014",
month = "10",
day = "1",
doi = "10.1089/met.2014.0045",
language = "English (US)",
volume = "12",
pages = "403--415",
journal = "Metabolic Syndrome and Related Disorders",
issn = "1540-4196",
publisher = "Mary Ann Liebert Inc.",
number = "8",

}

TY - JOUR

T1 - Do n-3 polyunsaturated fatty acids increase or decrease lipid peroxidation in humans?

AU - Kelley, Nirvair S.

AU - Yoshida, Yasukazu

AU - Erickson, Kent L

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Background: Despite many known health benefits of n-3 polyunsaturated fatty acids (PUFA), there is a concern that their high degree of unsaturation may actually increase oxidative stress, lipid peroxidation (LPO), and chronic inflammatory diseases.Methods: In this review, we have analyzed results from published human studies regarding the effects of n-3 PUFA supplementation on markers of lipid peroxidation.Results: Of the 22 published human studies, nine found no change, eight a decrease, and five an increase in markers of LPO. These inconsistencies may be due to methods, subject characteristics, dose, duration, fatty acid and antioxidant composition of supplements, and basal diets. Methods used for analysis seem to be the most significant factor. Six of eight studies with a decrease in LPO determined F2-isoprostanes produced in vivo, and two determined plasma antioxidant capacity or hydroperoxides. n-3 PUFA can serve as scavengers for free radicals and also modulate expression of genes that determine the balance between oxidative and antioxidative status. Recent studies that monitored oxidation products of cholesterol and fatty acids support the hypothesis that n-3 PUFA decrease LPO. Most of the studies showing no change or increase in LPO determined markers that involved ex vivo sample preparation or oxidation (malondialdehyde, low-density lipoprotein oxidation, lipid hydroperoxides).Conclusion: A majority of studies do not indicate that n-3 PUFA increased LPO. Future studies need to investigate the effects of dose, duration, and composition of n-3 PUFA with standardized diets and methods on concentrations and types of LPO products produced.

AB - Background: Despite many known health benefits of n-3 polyunsaturated fatty acids (PUFA), there is a concern that their high degree of unsaturation may actually increase oxidative stress, lipid peroxidation (LPO), and chronic inflammatory diseases.Methods: In this review, we have analyzed results from published human studies regarding the effects of n-3 PUFA supplementation on markers of lipid peroxidation.Results: Of the 22 published human studies, nine found no change, eight a decrease, and five an increase in markers of LPO. These inconsistencies may be due to methods, subject characteristics, dose, duration, fatty acid and antioxidant composition of supplements, and basal diets. Methods used for analysis seem to be the most significant factor. Six of eight studies with a decrease in LPO determined F2-isoprostanes produced in vivo, and two determined plasma antioxidant capacity or hydroperoxides. n-3 PUFA can serve as scavengers for free radicals and also modulate expression of genes that determine the balance between oxidative and antioxidative status. Recent studies that monitored oxidation products of cholesterol and fatty acids support the hypothesis that n-3 PUFA decrease LPO. Most of the studies showing no change or increase in LPO determined markers that involved ex vivo sample preparation or oxidation (malondialdehyde, low-density lipoprotein oxidation, lipid hydroperoxides).Conclusion: A majority of studies do not indicate that n-3 PUFA increased LPO. Future studies need to investigate the effects of dose, duration, and composition of n-3 PUFA with standardized diets and methods on concentrations and types of LPO products produced.

UR - http://www.scopus.com/inward/record.url?scp=84907288652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907288652&partnerID=8YFLogxK

U2 - 10.1089/met.2014.0045

DO - 10.1089/met.2014.0045

M3 - Article

C2 - 25045922

AN - SCOPUS:84907288652

VL - 12

SP - 403

EP - 415

JO - Metabolic Syndrome and Related Disorders

JF - Metabolic Syndrome and Related Disorders

SN - 1540-4196

IS - 8

ER -